Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor
- PMID: 11356952
- PMCID: PMC114257
- DOI: 10.1128/JVI.75.12.5457-5464.2001
Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor
Abstract
Human immunodeficiency virus type 1 (HIV-1) entry is triggered by the interaction of the gp120 envelope glycoprotein with a cellular chemokine receptor, either CCR5 or CXCR4. We have identified different mutations in human CXCR4 that prevent efficient infection by one HIV-1 strain (NDK) but not another (LAI) and sought to define these strain-dependent effects at the gp120 level. The lack of activity toward the NDK strain of the HHRH chimeric CXCR4 in which the second extracellular loop (ECL2) derived from the rat CXCR4 and of CXCR4 with mutations at an aspartic acid in ECL2 (D193A and D193R) was apparently due to the sequence of the third variable loop (V3) of gp120, more precisely, to its C-terminal part. Indeed, substitution of the LAI V3 loop or only its C-terminal part in the NDK gp 120 context was sufficient to restore usage of the HHRH, D193A, and D193R receptors. The same result was achieved upon mutation of a single lysine residue of the NDK V3 loop to alanine (K319A) but not to arginine (K319R). These results provide a strong case for a direct interaction between the gp120 V3 loop and the ECL2 domain of CXCR4. By contrast, V3 substitutions had no effect on the inability of NDK to infect cells via a mutant CXCR4 in which the amino-terminal extracellular domain (NT) is deleted. In experiments with a set of chimeric NDK-LAI gp120s, the V1/V2 region from LAI gp120 was both necessary and sufficient for usage of the NT-deleted CXCR4. Different variable domains of gp120 can therefore cooperate for a functional interaction with CXCR4.
Figures
Similar articles
-
Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.Virology. 1998 Sep 1;248(2):394-405. doi: 10.1006/viro.1998.9282. Virology. 1998. PMID: 9721247
-
N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.J Virol. 2001 Jul;75(13):5998-6006. doi: 10.1128/JVI.75.13.5998-6006.2001. J Virol. 2001. PMID: 11390601 Free PMC article.
-
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392. Virology. 1998. PMID: 9813203
-
Synthetic peptides for study of human immunodeficiency virus infection.Appl Biochem Biotechnol. 2002 Jul-Dec;102-103(1-6):41-7. doi: 10.1385/abab:102-103:1-6:041. Appl Biochem Biotechnol. 2002. PMID: 12396109 Review.
-
HIV entry inhibitors: mechanisms of action and resistance pathways.J Antimicrob Chemother. 2006 Apr;57(4):619-27. doi: 10.1093/jac/dkl027. Epub 2006 Feb 7. J Antimicrob Chemother. 2006. PMID: 16464888 Review.
Cited by
-
High-Sequence Diversity and Rapid Virus Turnover Contribute to Higher Rates of Coreceptor Switching in Treatment-Experienced Subjects with HIV-1 Viremia.AIDS Res Hum Retroviruses. 2017 Mar;33(3):234-245. doi: 10.1089/AID.2016.0153. Epub 2016 Oct 12. AIDS Res Hum Retroviruses. 2017. PMID: 27604829 Free PMC article.
-
Heterosexual transmission of human immunodeficiency virus type 1 subtype C: Macrophage tropism, alternative coreceptor use, and the molecular anatomy of CCR5 utilization.J Virol. 2009 Aug;83(16):8208-20. doi: 10.1128/JVI.00296-09. Epub 2009 Jun 10. J Virol. 2009. PMID: 19515785 Free PMC article.
-
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.J Virol. 2020 Feb 28;94(6):e01622-19. doi: 10.1128/JVI.01622-19. Print 2020 Feb 28. J Virol. 2020. PMID: 31852781 Free PMC article.
-
Current Status of 68Ga-Pentixafor in Solid Tumours.Diagnostics (Basel). 2022 Sep 2;12(9):2135. doi: 10.3390/diagnostics12092135. Diagnostics (Basel). 2022. PMID: 36140541 Free PMC article. Review.
-
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.J Virol. 2004 Jan;78(1):524-30. doi: 10.1128/jvi.78.1.524-530.2004. J Virol. 2004. PMID: 14671134 Free PMC article.
References
-
- Berger E A, Murphy P M, Farber J M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657–700. - PubMed
-
- Berson J F, Doms R W. Structure-function studies of the HIV-1 coreceptors. Semin Immunol. 1998;10:237–248. - PubMed
-
- Bleul C C, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer T A. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829–833. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials